Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Complementary and alternative therapies (CAM)
3. CAM in epilepsy
4. Therapies that fit into CAM
5. Outline
6. Scope of use of herbs by epilepsy patients
7. Regulatory aspects of herbs in U.S.
8. U.S. Regulation of Herbs
9. Standards set forth by the DSHEA
10. Quality control issues
11. Unmet medical needs in epilepsy
12. Epilepsy drug statistics (1)
13. Epilepsy drug statistics (2)
14. Why botanicals?
15. Botanical treatment for epilepsy
16. East Asian literature: herbs for epilepsy (1)
17. East Asian literature: herbs for epilepsy (2)
18. FDA guidance for botanical drug products
19. Chemicals in botanical drug products
20. Harvard epilepsy botanical program
21. Harvard epilepsy botanical program: goals
22. Harvard epilepsy botanical program: global team
23. Step 1: Identify
24. Step 2: Acquisition
25. Step 3: in vivo and in vitro models
26. Step 4: compound isolation and testing
27. Step 5: clinical trials
28. Extracts, mixtures and compounds
29. From tradition to bench to bedside
30. Alternative therapies: conclusions

Topics Covered

• Complementary and alternative therapies (CAM) in epilepsy
• Scope of use of herbs and regulatory aspects
• Standards set forth by the DSHEA
• Quality control issues
• Unmet medical needs
• Epilepsy drug statistics
• Why botanicals?
• East Asian literature of herbs
• FDA guidance
• Chemicals in botanical drug products
• Harvard epilepsy botanical program
• From tradition to bench to bedside

Links

Series:

• Epilepsy and Seizures

Categories:

• Clinical Practice
• Neuroscience

Therapeutic Areas:

• Neurology

Talk Citation

Publication History

• Published on May 3, 2011

Financial Disclosures

• Prof. Steven Schachter, Consultant: Cyberonics.